<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>21(1)</volume><submitter>Cheon JH</submitter><funding>Ferring Pharmaceuticals</funding><journal>Intestinal research</journal><pagination>161-167</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9911271</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis.</pubmed_title><pmcid>PMC9911271</pmcid><pubmed_authors>Cheon JH</pubmed_authors><pubmed_authors>Awadhi SA</pubmed_authors><pubmed_authors>Louis E</pubmed_authors><pubmed_authors>Paridaens K</pubmed_authors><pubmed_authors>Marquez JR</pubmed_authors><pubmed_authors>Rydzewska G</pubmed_authors><pubmed_authors>Travis SP</pubmed_authors><pubmed_authors>Begun J</pubmed_authors><pubmed_authors>Magro F</pubmed_authors><pubmed_authors>Dignass AU</pubmed_authors><pubmed_authors>Fullarton JR</pubmed_authors><pubmed_authors>Narula N</pubmed_authors><pubmed_authors>Moschen AR</pubmed_authors></additional><is_claimable>false</is_claimable><name>The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis.</name><description/><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2025-04-22T20:04:10.309Z</modification><creation>2025-04-06T02:56:52.155Z</creation></dates><accession>S-EPMC9911271</accession><cross_references><pubmed>35421913</pubmed><doi>10.5217/ir.2022.00006</doi></cross_references></HashMap>